| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
84,380 |
73,790 |
$13.06M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
56,954 |
40,198 |
$1.08M |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
18,670 |
14,525 |
$382K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
14,876 |
10,329 |
$381K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
6,195 |
4,183 |
$334K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
5,119 |
3,249 |
$254K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
3,814 |
2,473 |
$236K |
| 59425 |
|
2,401 |
1,749 |
$196K |
| 92551 |
|
17,960 |
12,511 |
$196K |
| 90686 |
|
13,741 |
9,253 |
$137K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,672 |
1,780 |
$128K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
1,239 |
884 |
$101K |
| 90651 |
|
2,009 |
1,514 |
$74K |
| 99215 |
Prolong outpt/office vis |
2,494 |
1,852 |
$64K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,612 |
2,020 |
$48K |
| 90746 |
|
780 |
720 |
$48K |
| G9920 |
Screening performed and negative |
2,956 |
2,208 |
$45K |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
1,520 |
970 |
$38K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,237 |
744 |
$29K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
722 |
510 |
$28K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
5,485 |
4,437 |
$27K |
| H1003 |
Prenatal care, at-risk enhanced service; education |
1,033 |
647 |
$26K |
| 90648 |
|
2,702 |
1,782 |
$23K |
| 90715 |
|
1,170 |
851 |
$22K |
| 90670 |
|
2,119 |
1,378 |
$20K |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
1,740 |
1,210 |
$20K |
| 99173 |
|
2,121 |
2,116 |
$13K |
| 90688 |
|
648 |
647 |
$12K |
| 90723 |
|
1,428 |
962 |
$11K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,599 |
2,382 |
$11K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
143 |
81 |
$9K |
| 90734 |
|
822 |
553 |
$9K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
135 |
97 |
$9K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,871 |
712 |
$8K |
| 99401 |
|
402 |
295 |
$7K |
| 90633 |
|
855 |
525 |
$7K |
| 99201 |
|
236 |
180 |
$7K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
1,038 |
764 |
$7K |
| H2000 |
Comprehensive multidisciplinary evaluation |
47 |
47 |
$6K |
| 81025 |
|
3,457 |
2,395 |
$6K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
80 |
58 |
$6K |
| 90674 |
|
316 |
316 |
$6K |
| 85018 |
|
5,636 |
3,985 |
$6K |
| 20610 |
|
147 |
74 |
$5K |
| 20553 |
|
129 |
88 |
$5K |
| 90710 |
|
331 |
233 |
$4K |
| 90677 |
|
525 |
377 |
$4K |
| 99188 |
|
472 |
304 |
$3K |
| 99381 |
|
40 |
39 |
$3K |
| 90620 |
|
43 |
43 |
$2K |
| 96158 |
|
129 |
85 |
$2K |
| 90685 |
|
130 |
130 |
$2K |
| 97803 |
|
119 |
95 |
$2K |
| 72100 |
|
130 |
130 |
$2K |
| 90621 |
|
237 |
167 |
$2K |
| 90656 |
|
362 |
269 |
$2K |
| J3490 |
Unclassified drugs |
57 |
41 |
$2K |
| 72072 |
|
95 |
95 |
$2K |
| 72040 |
|
108 |
108 |
$1K |
| 90681 |
|
204 |
159 |
$1K |
| 69210 |
|
38 |
36 |
$1K |
| 86580 |
|
217 |
196 |
$1K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
191 |
123 |
$932.71 |
| 71046 |
Radiologic examination, chest; 2 views |
69 |
56 |
$825.63 |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
13 |
12 |
$777.58 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
53 |
53 |
$704.70 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
51 |
46 |
$701.90 |
| 81002 |
|
626 |
394 |
$578.35 |
| 90696 |
|
33 |
24 |
$432.00 |
| 81003 |
|
190 |
174 |
$405.60 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
244 |
234 |
$362.25 |
| T1999 |
Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" |
104 |
45 |
$267.37 |
| 90716 |
|
23 |
12 |
$234.00 |
| 90700 |
|
26 |
13 |
$234.00 |
| S9445 |
Patient education, not otherwise classified, non-physician provider, individual, per session |
13 |
12 |
$218.66 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
43 |
27 |
$169.24 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
24 |
23 |
$156.73 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
46 |
34 |
$36.00 |
| 96161 |
|
1,094 |
1,094 |
$15.01 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
127 |
127 |
$8.92 |
| Z1034 |
|
2,053 |
1,550 |
$0.00 |
| Z6410 |
|
804 |
411 |
$0.00 |
| 3074F |
|
111 |
93 |
$0.00 |
| Z6406 |
|
590 |
421 |
$0.00 |
| Z1038 |
|
14 |
13 |
$0.00 |
| Z6204 |
|
377 |
271 |
$0.00 |
| Z1032 |
|
12 |
12 |
$0.00 |
| Z6304 |
|
238 |
156 |
$0.00 |
| Z6400 |
|
203 |
202 |
$0.00 |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
276 |
276 |
$0.00 |
| 3078F |
|
108 |
91 |
$0.00 |
| Z6500 |
|
45 |
45 |
$0.00 |